Despite there being a wide variety of symptoms reported in pediatric long COVID, one condition that has become increasingly recognized is orthostatic intolerance (OI), which can cause significant morbidity, limiting activities of daily living. This study examines rates of OI in 92 children with long COVID who underwent a bedside passive standing test in a pediatric post-COVID-19 rehabilitation clinic. Seventy-one percent met criteria for an orthostatic condition, including postural orthostatic tachycardia syndrome (POTS), orthostatic tachycardia (OT), classic orthostatic hypotension (OH), delayed OH, and orthostatic hypertension. Our findings suggest that OI is common in pediatric long COVID, necessitating appropriate clinical screening and treatment.
PellegrinoRChiappiniELicariAGalliLMarsegliaGL.Prevalence and clinical presentation of long COVID in children: a systematic review. Eur J Pediatr. 2022;181(12):3995-4009.
9.
MorrowAKMaloneLAKokorelisC, et al. Long-term COVID 19 sequelae in adolescents: the overlap with orthostatic intolerance and ME/CFS. Curr Pediatr Rep. 2022;10(2):31-44.
10.
StewartJMBorisJRChelimskyG, et al. Pediatric disorders of orthostatic intolerance. Pediatrics. 2018;141(1):e20171673.
11.
van CampenCLMCVerheugtFWARowePCVisserFC.Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract. 2020;5:50-58.
12.
KokorelisCMaloneLByrneK, et al. Onset of postural orthostatic tachycardia syndrome (POTS) following COVID-19 infection: a pediatric case report. Clin Pediatr (Phila). 2023;62(2):92-95.
13.
BuchhornR.Therapeutic approaches to dysautonomia in childhood, with a special focus on long COVID. Children (Basel). 2023;10:316.
14.
BorisJR.Postural orthostatic tachycardia syndrome in children and adolescents. Auton Neurosci. 2018;215:97-101.
15.
ShigeyasuYOkadaAFujiiC, et al. Quality of life and physical/psychosocial factors in children and adolescents with orthostatic intolerance. Biopsychosoc Med. 2023;17:23.
16.
RomaMMardenCLRowePC.Passive standing tests for the office diagnosis of postural tachycardia syndrome: new methodological considerations. Fatigue. 2018;6:179-192.
17.
PlashWBDiedrichABiaggioniI, et al. Diagnosing postural tachycardia syndrome: comparison of tilt test versus standing hemodynamics. Clin Sci (Lond). 2013;124:109-114.
18.
BlitshteynSWhitesonJHAbramoffB, et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 2022;14(10):1270-1291.
19.
VerninoSBourneKMStilesLE, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting—Part 1. Auton Neurosci. 2021;235:102828.
20.
FreemanRWielingWAxelrodFB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69-72.
21.
ZhaoJHanZZhangX, et al. A cross-sectional study on upright heart rate and BP changing characteristics: basic data for establishing diagnosis of postural orthostatic tachycardia syndrome and orthostatic hypertension. BMJ Open. 2015;5:e007356.
22.
BorisJRHuangJBernadzikowskiT.Orthostatic heart rate does not predict symptomatic burden in pediatric patients with chronic orthostatic intolerance. Clin Auton Res. 2020;30:19-28.
23.
BorisJRBernadzikowskiT.Demographics of a large paediatric Postural Orthostatic Tachycardia Syndrome Program. Cardiol Young. 2018;28(5):668-674.
24.
RuziehMGrubbBP.Orthostatic intolerance and postural tachycardia syndrome: new insights into pathophysiology and treatment. Herzschrittmacherther Elektrophysiol. 2018;29(2):183-186.
25.
LeeCGreenwoodDCMasterH, et al. Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: a multicenter study. J Med Virol. 2024;96(3):e29486.
26.
SeeleyM-CGallagherCOngE, et al. High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long-COVID: Implications for management and healthcare planning [published online ahead of print June 29, 2023]. Am J Med. doi:10.1016/j.amjmed.2023.06.010.
27.
HiraRBakerJRSiddiquiT, et al. Objective hemodynamic cardiovascular autonomic abnormalities in post-acute sequelae of COVID-19. Can J Cardiol. 2023;39:767-775.
28.
OrmistonCKŚwiątkiewiczITaubPR.Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19(11):1880-1889.
29.
JammoulMNaddourJMadiA, et al. Investigating the possible mechanisms of autonomic dysfunction post-COVID-19. Auton Neurosci. 2023;245:103071.
30.
FuQLevineBD.Exercise and non-pharmacological treatment of POTS. Auton Neurosci. 2018;215:20-27.
31.
van CampenCLMCRowePCVisserFC.Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome). J Transl Med. 2021;19:193.
32.
BlitshteynSWhitelawS.Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69:205-211.
33.
SeeleyMCGallagherCOngE, et al. Poor health-related quality of life in postural orthostatic tachycardia syndrome in comparison with a sex- and age-matched normative population. Clin Auton Res. 2023;33(4):469-477.
34.
MoonJKimD-YByunJ-I, et al. Orthostatic intolerance symptoms are associated with depression and diminished quality of life in patients with postural tachycardia syndrome. Health Qual Life Outcomes. 2016;14:144.
35.
Benrud-LarsonLMDewarMSSandroniP, et al. Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc. 2002;77:531-537.
36.
MillerAJRajSR.Pharmacotherapy for postural tachycardia syndrome. Auton Neurosci. 2018;215:28-36.
